Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristine J Hare

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Vitamins and Hormones|November 25, 2010
Incretin-based therapy and type 2 diabetesKristine J Hare, Filip K Knop
American Journal of Physiology. Endocrinology and Metabolism|January 28, 2010
Inappropriate glucagon response after oral compared with isoglycemic intravenous glucose administration in patients with type 1 diabetesKristine J Hare, Tina Vilsbøll, Jens J Holst, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|November 27, 2013
Sharp compared with blunt fascial incision at cesarean delivery: a randomized controlled trial with each case as her own controlAnna J M Aabakke, Kristine J Hare, Lone Krebs, et al.
European Journal of Gastroenterology & Hepatology|January 28, 2005
Tissue levels and post-prandial secretion of the intestinal growth factor, glucagon-like peptide-2, in controls and inflammatory bowel disease: comparison with peptide YYPeter T Schmidt, Tryggve Ljung, Bolette Hartmann, et al.
Diabetes|February 13, 2010
The glucagonostatic and insulinotropic effects of glucagon-like peptide 1 contribute equally to its glucose-lowering actionKristine J Hare, Tina Vilsbøll, Meena Asmar, et al.
The Journal of Clinical Endocrinology and Metabolism|October 20, 2009
Preserved inhibitory potency of GLP-1 on glucagon secretion in type 2 diabetes mellitusKristine J Hare, Filip K Knop, Meena Asmar, et al.
Regulatory Peptides|November 17, 2006
Metabolism of glucagon-like peptide-2 in pigs: role of dipeptidyl peptidase IVLene Hansen, Kristine J Hare, Bolette Hartmann, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 1, 2013
Postprandial gut hormone responses and glucose metabolism in cholecystectomized patientsDavid P Sonne, Kristine J Hare, Pernille Martens, et al.
Acta Obstetricia Et Gynecologica Scandinavica|March 13, 2019
Targeted Rhesus immunoglobulin for RhD-negative women undergoing an induced abortion: A clinical pilot studyMia P S Jensen, Merete B Damkjaer, Frederik B Clausen, et al.
The Journal of Clinical Endocrinology and Metabolism|July 19, 2023
Signs of a Glucose- and Insulin-Independent Gut-Bone Axis and Aberrant Bone Homeostasis in Type 1 DiabetesBolette Hartmann, Miriam Longo, David S Mathiesen, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Vitamins and Hormones|November 25, 2010
Incretin-based therapy and type 2 diabetesKristine J Hare, Filip K Knop
American Journal of Physiology. Endocrinology and Metabolism|January 28, 2010
Inappropriate glucagon response after oral compared with isoglycemic intravenous glucose administration in patients with type 1 diabetesKristine J Hare, Tina Vilsbøll, Jens J Holst, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|November 27, 2013
Sharp compared with blunt fascial incision at cesarean delivery: a randomized controlled trial with each case as her own controlAnna J M Aabakke, Kristine J Hare, Lone Krebs, et al.
European Journal of Gastroenterology & Hepatology|January 28, 2005
Tissue levels and post-prandial secretion of the intestinal growth factor, glucagon-like peptide-2, in controls and inflammatory bowel disease: comparison with peptide YYPeter T Schmidt, Tryggve Ljung, Bolette Hartmann, et al.
Diabetes|February 13, 2010
The glucagonostatic and insulinotropic effects of glucagon-like peptide 1 contribute equally to its glucose-lowering actionKristine J Hare, Tina Vilsbøll, Meena Asmar, et al.
The Journal of Clinical Endocrinology and Metabolism|October 20, 2009
Preserved inhibitory potency of GLP-1 on glucagon secretion in type 2 diabetes mellitusKristine J Hare, Filip K Knop, Meena Asmar, et al.
Regulatory Peptides|November 17, 2006
Metabolism of glucagon-like peptide-2 in pigs: role of dipeptidyl peptidase IVLene Hansen, Kristine J Hare, Bolette Hartmann, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 1, 2013
Postprandial gut hormone responses and glucose metabolism in cholecystectomized patientsDavid P Sonne, Kristine J Hare, Pernille Martens, et al.
Acta Obstetricia Et Gynecologica Scandinavica|March 13, 2019
Targeted Rhesus immunoglobulin for RhD-negative women undergoing an induced abortion: A clinical pilot studyMia P S Jensen, Merete B Damkjaer, Frederik B Clausen, et al.
The Journal of Clinical Endocrinology and Metabolism|July 19, 2023
Signs of a Glucose- and Insulin-Independent Gut-Bone Axis and Aberrant Bone Homeostasis in Type 1 DiabetesBolette Hartmann, Miriam Longo, David S Mathiesen, et al.
Pageof 2